El informe
Análisis profundos sobre financiación de empresas, estrategias de crecimiento e insights de mercado de los negocios más innovadores del mundo
52 informes y contando
Serán Bioscience Raises $200M in Venture
Serán Bioscience, a Biotech company based in Bend, OR, has raised $200M in Venture at a $900M valuation led by Foresite Capital, OrbiMed.
Seran Bioscience Raises $215M in Series C
Seran Bioscience, a HealthTech company based in San Diego, CA, has raised $215M in Series C from multiple investors.
Seran Bioscience raises $215M Series C
Seran Bioscience raises $215M in Series C. Biotech developing precision therapeutics for complex diseases...
Serán Bioscience raises $200M Venture at $900M valuation
Serán Bioscience raises $200M in Venture at $900M valuation. Provides development and manufacturing services to pharmaceutical and biotech companies...
Treeline Biosciences Raises $200M in Series A
Treeline Biosciences, a HealthTech company based in San Diego, CA, has raised $200M in Series A from multiple investors.
Retro Biosciences Raises $1B in Seed
Retro Biosciences, a HealthTech company based in San Francisco, CA, has raised $1B in Seed led by Sandro Salsano.
Syndeio Biosciences Raises $90M in Series
Syndeio Biosciences, a Biotech company based in Indianapolis, IN, has raised $90M in Series at a $450M valuation led by Eli Lilly and Company, ARCH Venture Partners.
Colossal Biosciences Raises $120M in Series
Colossal Biosciences, a Biotech company based in Austin, TX, has raised $120M in Series at a $800M valuation led by CIA In-Q-Tel, Breyer Capital.
Ollin Biosciences Raises $100M in Series A
Ollin Biosciences, a Biotech company based in Austin, TX, has raised $100M in Series A at a $500M valuation led by Deerfield Management, ARCH Venture Partners.
Mostrando 9 informes • Página 1 • Categoría: all
Mantente a la vanguardia del mercado
Recibe insights semanales en tu bandeja de entrada. Sin spam, solo inteligencia.